SlideShare a Scribd company logo
urinary lithiasis
module: men’s health
Objectives
• to be able to enumerate the different causes of urinary stones
• to be able to discuss the pathogenesis of stone formation
• to be able to explain the different Physicochemical phases of stone
formation
• to be enumerate the different inhibitors of crystal formation
• To be able to discuss the classification of renal stones
References:
• Campbell-Walsh Urology 10th ed
• https://scialert.net/fulltext/?doi=ajdd.2017.54.62#424020_ja
• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410535/
• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250668/
epidemiology of renal calculi
• Global annual prevalence rate: 3% - 5%
• Life time prevalence: 15%-25%
• rate of recurrence after 1st time:
• 1st year: 14%
• 5th year: 35%
• 10th year: 52%
epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• typically affects adult males than adult
women
• however, according to a study
“..resource utilization for urinary stone
disease rose 22% for men and 52% for
women, reflecting an increasing
resource use in women compared to
men.” --
epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• prevalence by Race is highest among
white males> Hispanics> Asians>
African-Americans
epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• uncommon < 20 years old
• peak incidence: 4th to 6th decade of life
• in women, bimodal distribution of
stone disease occurs
• a 2nd peak occurs on the 6th decade
corresponding to the onset of
menopause
epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• roughly follows environmental risk
factors
• higher prevalence in:
• hot
• arid
• dry climates
epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• seasonal variation in stone disease is
likely related to temperature by way of
fluid losses from perspiration &
sunlight induced increases in vitamin D
epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• occupational risk factors:
• heat exposure
• dehydration
• occupations associated with increase risk:
• cooks
• engineering personnel
• steel workers
epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• prevalence & incident risk are directly
correlated with weight and BMI in both
sexes
• higher BMI associated w/ increase
excretion of:
• Urinary oxalate
• Uric Acid
• Sodium
• Phosphorus
epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• urinary supersaturation of uric acid
increases with increasing BMI
• association of obesity w/ calcium oxalate
stone formation is primarily due to
increased excretion of promoters of stone
formation
• association of obesity and uric acid stone
is primarily influenced by urinary pH
epidemiology of renal calculi
• Gender
• Race/Ethnicity
• Age
• Geography
• Climate
• Occupation
• BMI & Weight
• Water
• water intake is inversely related to
kidney stone formation
• geographical differences on incidence
of stone disease have been associated
to the difference in the mineral &
electrolyte content of water
physicochemistry
• stone formation is a cascade of events that occurs as the glomerular
filtrate traverses the nephron
• starts w/ urine becoming supersaturated w/ respect to stone forming
salts
• crystals that are formed may flow with the urine
• however, some crystals become retained in the kidney thru anchoring
sites that promote growth and aggregation of crystal leading to stone
formation
physicochemistry
state of saturation
• concentration product: a solution containing ions/ molecules of a
sparingly soluble salt
• Saturated solution: a state when a pure aqueous solution of a salt
reaches the point at which no further added salt crystals will dissolve
• addition of crystals to a saturated solution will cause crystals to
precipitate
• precipitation is influenced by:
• urine pH
• temperature
physicochemistry
state of saturation
• in urine however, crystallization does not necessarily occur because
of the presence of inhibitors and other molecules that may allow
higher concentration of salts without precipitation
• urine is considered to be metastable with respect to the salt
• Formation product: the point where the metastable state of urine can
no longer be held in solution so that crystal would already form
physicochemistry
state of saturation
• Three major states of saturation
in urine:
• undersaturated
• metastable
• unstable
• crystals would not form
• dissolution of crystals
theoretically can be done
physicochemistry
state of saturation
• Three major states of saturation
in urine:
• undersaturated
• metastable
• unstable
• state were most common
stone components reside
• precipitation does not occur
• modulation of factors
controlling stone formation
may be done
• therapeutic intervention is
performed at this state
physicochemistry
state of saturation
• Three major states of saturation
in urine:
• undersaturated
• metastable
• unstable
• nucleation will occur
• inhibitors not generally effective
physicochemistry
metastable urine state
• crystal growth can occur on existing crystal, but de novo formation of
crystals cannot occur in the length of time it normally takes for the
filtered urine to reach the bladder
• BUT crystal formation may occur on certain conditions
physicochemistry
metastable urine state: circumstances when crystals may grow
1. parts of the nephron where local concentration products may
exceed the formation product for long enough time periods to allow
nucleation to occur
2. local areas of obstruction/ stasis in the upper urinary tract may
prolong urinary transit time and allow crystals to form
3. microscopic impurities/ other constituents in the urine can facilitate
the nucleation process by absorption of the crystal components in a
geometric way that ensemble the native crystals
physicochemistry
Nucleation & Crystal growth, aggregation and retention
• Homogenous nucleation is the process by which nuclei form in pure
solution
• Nuclei are the earliest crystal structure that does not dissolve
• Small nuclei is unstable favoring dissolution of the crystal over crystal
growth
• Nuclei would persist if:
• supersaturation level is reached
• size of the crystal is adequate
• urine transit time is longer that the lag time to nucleation
physicochemistry
Nucleation & Crystal growth, aggregation and retention
• crystal growth occurs when:
• promoters stabilize the nuclei
thus providing a surface with
a binding site that
accommodates the crystal
structure of the nucleus
• crystal nuclei usually form
through heterogeneous
nucleation by adsorption
onto existing surfaces of
epithelial cells, cell debris or
other crystals
• Inhibitors of crystal growth
• Magnesium
• Citrate
• Nephrocalcin
• Tamm-Horsfall mucoprotein
• Uropontin
• Bikunin
physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• starts with formation of crystals
inside the nephron
• if the crystals are removed it
becomes harmless crystalluria
• if not, retention of crystals leads
either to:
• particles too large to pass
• particles adhere to damaged
cells
physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• retained crystals can:
• enter the interstitium
• form plugs inside tubules/ ducts
of Bellini
• crystal plugs were seen in patients
w/:
• primary hyperoxaluria
• primary hyperparathyroidism
• enteric hyperoxaluria
• distal renal tubular acidosis
physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• these conditions have increase
serum and renal load of Calcium,
Oxalate & Cystine:
• primary hyperoxaluria
• primary hyperparathyroidism
• enteric hyperoxaluria
• high renal load leads to increased
intratubular concentrations further
increasing crystallization
physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism,
tubular plugs
• Fixed-particle mechanism,
papillary plaques
• overall, plugs consist of random
aggregates formed due to an
acute high supersaturation of
stone components
physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• initial step in papillary plaque
formation is precipitation of
calcium phosphate in the
interstitium around the bends of
the longest loops of Henle
• with alternating accumulation of
crystal components and organic
material these deposits increase in
size
• the growing plaque gets exposed to
the urine space outside the papilla
physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism, tubular
plugs
• Fixed-particle mechanism, papillary
plaques
• Plaque formation in the
interstitium may form during
periods of increased reabsorption
of calcium & phosphate
• this leads to a supersaturation in
the interstitial space
• since water in the interstitium is
static this allows the salts to
crystalize
physicochemistry
two views on formation & growth of crystals
• Free-particle mechanism,
tubular plugs
• Fixed-particle mechanism,
papillary plaques
• overall, this mechanism contains
an initial period of deposition
outside the dynamics of urine
flow
• this is followed by growth and
eventual exposure to urine
physicochemistry
inhibitors & promoters of crystal formation
• presence of molecules that raises the supersaturation needed to
initiate crystal nucleation/ reduce rate of crystal growth to prevent
stone formation have been identified
• Known Inhibitors of crystal formation:
• Citrate
• Magnesium
• Pyrophosphate
physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of crystal
formation:
• Citrate
• Magnesium
• Pyrophosphate
• acts as an inhibitor of calcium
oxalate and calcium phosphate
stone formation by:
• complexes with calcium to
decrease available ionic
calcium for binding with
oxalate or phosphate
• inhibits spontaneous
precipitation of calcium
oxalate
physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of crystal
formation:
• Citrate
• Magnesium
• Pyrophosphate
• acts as an inhibitor of calcium
oxalate and calcium phosphate
stone formation by: cont..
• prevents agglomeration of
calcium oxalate
• reduced calcium phosphate
growth
• prevents heterogeneous
nucleation of calcium oxalate
by monosodium urate
physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of
crystal formation:
• Citrate
• Magnesium
• Pyrophosphate
• it’s action is derived from its complex
with oxalate
• this complex reduces available ionic
oxalate concentrations and decrease
calcium oxalate supersaturation
• it also reduces the rate of calcium
oxalate crystal growth
physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of
crystal formation:
• Citrate
• Magnesium
• Pyrophosphate
• inorganic pyrophosphate is
responsible for 25% - 50% of the
inhibitory activity of whole urine
against calcium phosphate
crystallization
physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of calcium
oxalate monohydrate crystal
aggregation:
• Nephrocalcin
glycoprotein
• Tamm-Horsfall
glycoprotein
• Osteopontin/ Uropontin
• is an acidic glycoprotein that is
synthesized in the proximal
convoluted tubules and the thick
ascending limb
• inhibits growth of calcium oxalate
monohydrate crystals
physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of calcium
oxalate monohydrate crystal
aggregation:
• Nephrocalcin
glycoprotein
• Tamm-Horsfall
glycoprotein
• Osteopontin/ Uropontin
• expressed by renal epithelial cells in the
thick ascending limb and distal
convoluted tubule as a membrane-
anchored protein that is released into
the urine after the anchoring site is
cleaved by phospholipase or proteases
• most abundant protein in the urine
• potent inhibitor of calcium oxalate
crystal aggregation
physicochemistry
inhibitors & promoters of crystal formation
• Known Inhibitors of
calcium oxalate
monohydrate crystal
aggregation:
• Nephrocalcin
• Tamm-Horsfall
glycoprotein
• Osteopontin/
Uropontin
• expressed in bone matrix and renal
epithelial cells of the ascending limb
of the loop of Henle and distal tubule
• inhibits nucleation, growth and
aggregation of calcium oxalate crystal
• also reduces binding of crystals to
renal epithelial cells
mineral metabolism
• Calcium absorption primarily occurs in the small intestines at a rate
that is dependent on calcium intake
• 1,25-Dihydroxyvitamin D, is the most potent stimulator of intestinal
calcium absorption
• PTH stimulate 1α-hydroxylase in the proximal tubule of the kidney to
convert 25-dihydroxyvitamin D3 to 1,25(OH)2D3
• PTH enhances proximal tubular reabsorption of calcium and renal
phosphate excretion
• Intestinal oxalate absorption is influenced by luminal calcium,
magnesium and oxalate-degrading bacteria
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous Stones
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• nearly 75% of all urinary calculi contain
calcium
• Hypercalciuria
• most common abnormality identified
• but not all persons w/ hypercalciuria
develop stones
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hypercalciuria
• stone formation may occur with:
• increase urinary saturation of calcium
salts
• decrease inhibitory activity of citrate
& chondroitin sulfate
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hypercalciuria
• definitions:
• > 200 mg urinary calcium/day, after
adherence to a 400 mg calcium, 100
mg sodium diet x 1 week (Menon, 1986)
• excretion of greater than 4
mg/kg/day or greater than 7
mmol/day in men and 6 mmol/day
in women (Parks and Coe, 1986)
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hyperoxaluria
• definitions: urinary oxalate >40 mg/day
• leads to urinary saturation of calcium
oxalate that leads to calcium oxalate
stones formation
• it is also involve in crystal growth and
retention by means of renal tubular
cell injury by lipid peroxidation and
generation of oxygen free radicals
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous Stones
• Hyperoxaluria may be due to:
• primary hyperoxaluria
• derangement in biosynthesis
• enteric hyperoxaluria
(malabsorption conditions)
• inflammatory bowel disease
• celiac sprue
• intestinal resection
• Dietary hyperoxaluria
• excessive dietary intake of
vitamin C
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hyperuricosuria
• urinary uric acid > 600mg/day
• 10% of calcium stone formers have
hyperuricosuria as the only
abnormality
• most common cause is increase dietary
intake of purine
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hypocitraturia
• urinary citrate level of:
• < 320 mg/day (Park, 1987)
• < 0.6 mmol (men), 1.03 mmol
(women)/day (Menon and Mahle, 1983)
• cause by:
• metabolic acidosis due to enhanced
renal tubular reabsorption
• decrease synthesis of citrate in
peritubular cells
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Low Urine pH
• defined as: < 5.5
• may be due to:
• high amount of dissociated uric acid
• chronic metabolic acidosis
• gouty diathesis- formation of
urinary stones in persons w/ 1o gout
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous Stones
• Renal Tubular Acidosis
• characterized by metabolic
acidosis resulting from
defects in renal tubular
hydrogen ion secretion/
bicarbonate reabsorption
• Types of RTA:
• Type 1
• Type II
• Type III
Renal Tubular Acidosis
• Normal: kidney must reabsorb filtered bicarbonate to maintain
buffering action
• Excess acid must likewise be excreted
• failure of the two mechanism lead to metabolic acidosis:
• decrease buffer (bicarbonate)
• increase acid (decrease acid secretion in the tubules)
• RTA occurs due to an impairment of
• net acid excretion (Type1)
• reabsorption of bicarbonate (Type 2)
types of renal tubular acidosis
• Type 1 (Distal)
• Type 2 (Proximal)
• Type 4 (Distal)
• characterized by an abnormal collecting duct
function w/c is the inability to acidify the
urine in the presence of systemic acidosis
• classic findings:
• hypokalemia
• hypercholerimia
• non-anion gap metabolic acidosis
• nephrocalcinosis
• elevated urine (>6.0)
types of renal tubular acidosis
• Type 1 (Distal)
• Type 2 (Proximal)
• Type 4 (Distal)
• most common associated stone is Calcium
Phosphate because of:
• hypercalciuria
• hypocitraturia: most important factor in
stone formation for type 1
• increased urinary pH
• Metabolic acidosis promote:
• bone demineralization
• which lead to hyperparathyroidism
• Hypercalceuria
types of renal tubular acidosis
• Type 1 (Distal)
• Type 2
(Proximal)
• Type 4 (Distal)
• characterized by a defect in bicarbonate
reabsorption associated with:
• initial high urine pH that normalizes as
plasma HCO3
- decreases
• decrease in amount of filtered HCO3
-
• nephrolithiasis is uncommon due to a
normal citrate excretion
• affects the proximal tubule function
• Stone is not common due to a normal
citrate excretion
types of renal tubular acidosis
• Type 1 (Distal)
• Type 2
(Proximal)
• Type 4 (Distal)
• associated w/ chronic renal damage
seen in patients w/
• interstitial renal disease
• diabetic nephropathy
• stone formation is not common due to
a reduced excretion of stone-forming
substances such as calcium and uric
acid
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Hypomagnesuria
• rare cause of nephrolithiasis
• magnesium binds with oxalate and
calcium thus reducing Mg inhibitory
activity
• Low urinary Mg level associated with
decreased urinary citrate levels, w/c.
further contributes to stone formation
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous Stones
• determinants of uric acid stone formation
• low pH
• most important pathogenic factor
• low urine volume
• hyperuricosuria
• stone formation may be due to:
• congenital causes
• acquired causes
• idiopathic causes
uric acid stone formation
causes
• Congenital disorders
• Acquired
• Idiopathic
• associated with:
• Defects in renal tubular urate
reabsorption
• Lesch-Nyhan syndrome
• 1o a defect in purine metabolism
• deficiency of hypoxanthine-guanine
phosphoribosyltransferase (HGPRT)
• leads to build up of uric acid in all
body fluids
uric acid stone formation
causes
• Congenital disorders
• Acquired
• Idiopathic
• associated with:
• Familial Juvenile Gouty Nephropathy
• characterized by elevated serum
uric acid concentrations
• due to abnormal reabsorption of
uric acid
uric acid stone formation
causes
• Congenital disorders
• Acquired
• Idiopathic
• chronic diarrhea
• volume depletion
• myeloproliferative disorders
• high animal protein intake
• intake of uricosuric drugs (ex.
colchicine, allopurinol)
uric acid stone formation
causes
• Congenital disorders
• Acquired
• Idiopathic
• gouty diathesis/ idiopathic low urine pH
• manifest with:
• normal uric acid levels (does not
have gout)
• acidic urine
• Hyperuricosuric calcium nephrolithiasis
• manifest with:
• hyperuricosuria
• normal urine pH
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• main component is cystine
• due to crystallization of cystine in urine
• Factors determining crystallization of
cystine in urine:
• urinary cystine concentration
• urine pH
• ionic strength
• urinary macromolecules
Factors determining crystallization of cystine
in urine
• urinary cystine
concentration
• urine pH
• ionic strength
• urinary macromolecules
• supersaturation of cystine in the
urine is the main contributor
• due to:
• no specific inhibitor for cystine
crystallization
• poor solubility of cystine in
urine
Factors determining crystallization of cystine
in urine
• urinary cystine
concentration
• urine pH
• ionic strength
• urinary macromolecules
• cystine solubility is pH
dependent
• Solubility of cystine at particular
pH:
• 300 mg/L : pH 5
• 400 mg/L: pH 7
• 1000 mg/L: pH 9
• Average urine pH: 6
Factors determining crystallization of cystine
in urine
• urinary cystine
concentration
• urine pH
• ionic strength
• urinary macromolecules
• Ionic strength influences the
solubility of cystine
• so that an increase in ionic
strength of urine from 0.005 to
0.3 will allow an addition of 70
mg of cystine to be dissolved
Factors determining crystallization of cystine
in urine
• urinary cystine
concentration
• urine pH
• ionic strength
• urinary macromolecules
• colloids can also increase
cystine solubility
• but the mechanism is still
unclear
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• primarily composed of Magnesium
Ammonium Phosphate Hexahydrate called
struvite
• prerequisite in its formation is infection
with a urease-producing bacteria
• urinary urea is hydrolyzed to ammonia +
CO2 (produces alkaline urine, pH 7.2 - 8.0)
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• but alkaline pH favors the formation of
ammonia
• however in the presence of urease,
ammonia continues to be produced
despite the alkaline pH
• this further increases the pH of urine
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Alkaline pH also promotes hydration of CO2 to
Carbonic acid
• Carbonic acid dissociates into bicarbonate + 2
Hydrogen ions
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Dihydrogen phosphate in the alkaline urine
promotes dissociation to produce phosphate
ions
• Add Magnesium into the mixture you would
have:
• Ammonium + Phosphate + Magnesium =
Magnesium Ammonium Phosphate
• Infection stones may also be exacerbated with:
• urinary obstruction
• urine stasis
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Calcium Stones
• Uric Acid Stones
• Cystine Stones
• Infection Stones
• Miscellaneous
Stones
• Common pathogens associated:
• Proteus
• P. mirabilis: most common organism
causing struvite stones
• Klebsiella
• Pseudomonas
• Staphylococcus
• incidence is higher in women than in men
(2:1)
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• radiolucent stone formed due to:
• congenital deficiency of
xanthine oxidase
• results into plasma
accumulation and excess
urinary excretion of xanthine
• xanthine is poorly soluble in
urine leading to
supersaturation with the
subsequent development of
xanthine stones
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• radiolucent stone formed due to:
• congenital deficiency of adenine
phosphoribosyltransferase
(APRT)
• leads to formation and
hyperexcretion of
dihydroxyadenine (DHA)
• low solubility of DHA leads
to precipitation and
formation of urinary crystals
that may grow and form
urinary stones
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• rare cause of urinary stones,
seen in <1% of all stone formers
• conditions associated include:
• laxative abuse
• recurrent UTI
• recurrent uric acid stone
formation
• inflammatory bowel disease
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• Pathophysiology has been postulated
to be due to:
• dehydration 2o GI losses (from
abuse of laxatives) causing:
• intracellullar acidosis
• enhanced ammonia excretion
• Urinary sodium is low because of
dehydration
• urate complexes with ammonia
leading to urinary supersaturation
of ammonium acid urate
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• also known as fibromas/ colloid
calculi/ albumin calculi
• such stones are made of
mucopolysaccharide (1/3) + protein
(2/3)
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• most common amino acids found
were:
• threonine
• leucine
• serine
• tyrosine
• arginine
• lysine
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• formation may be due to:
• direct precipitation and
crystallization of a drug or its
metabolite
• indirectly by altering the urinary
environment favorable for
metabolic stone formation
pathogenesis of upper urinary tract calculi
classification of nephrolithiasis
• Miscellaneous Stones
• Xanthine & Dihydroxyadenine
Stones
• Ammonium Acid Urate
Stones
• Matrix Stones
• Medication-Related Stones
• Drugs associated with calcium stone
formation
• loop diuretics (furosemide)
• acetazolamide: a carbonic
anhydrase inhibitor
• topiramate: use for seizure
disorders and migraine
• zonisamide: sulfonamide
anticonvulsant and carbonic
anhydrase inhibitor
anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• incidence of renal stones in this
abnormality is about 20%
• however studies show that
metabolic abnormalities play a big
role in the development of urinary
stones among these patients
anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• evidence on the role of metabolic
predisposition:
• high rate of recurrence of stone
formation after correction
• metabolic evaluation
demonstrated an underlying
metabolic abnormality
• type and distribution of
metabolic abnormality
identified in UJO patients where
similar to the general population
anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• therefore: correction of UPJ
obstruction does not prevent stone
formation from recurring
anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• occurs in 0.25% of the
population and renal stone
incidence among them is 20%
• because of the high insertion of
the ureter into the renal pelvis
there is impairment of urine
drainage
anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• Although, risk of stone
formation has been related to
urinary stasis
• underlying metabolic
abnormalities are still needed
for the formation of stones
anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• associated in 40% of patients w/
stones
• unclear if the stone formation is
caused by local obstruction or
because of metabolic factors
anatomic predisposition to stone formation
• Ureteropelvic Junction Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• characterized by ectasia of the renal
collecting ducts
• associated with:
• recurrent infection
• urinary stasis
• hypercalciuria
• impaired renal concentrating
ability
• defective urinary acidification
anatomic predisposition to stone formation
• Ureteropelvic Junction
Obstruction
• Horseshoe kidneys
• Caliceal Diverticula
• Medullary sponge kidney
• possible contributing factor for
stone formation:
• defective renal acidification
• Hypercalciuria
• Hypocitraturia
stones in pregnancy
• physiologic changes during pregnancy may enhance stone formation
• physiologic hydronephrosis brought about by:
• high levels of progesterone
• compression of the ureters by the gravid uterus
• Hydronephrosis may persist up to 4 to 6 weeks postpartum
• physiologic dilatation may:
• promote crystallization due to urinary stasis
• increase renal pelvic pressure
stones in pregnancy
• Other physiologic changes that may modulate risk factors for the
development of urinary stone
• increase renal blood flow
• increase GFR
• increase filtered loads of:
• calcium
• sodium
• uric acid
thank you
• supplementary online material:
• https://scialert.net/fulltext/?doi=ajdd.2017.54.62#424020_ja
• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410535/
• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250668/

More Related Content

Similar to urolithiasis by dr newaz

Dental calculus and predisposing factors
Dental calculus and predisposing factorsDental calculus and predisposing factors
Dental calculus and predisposing factors
madhavi Nagireddy
 
Seminar renal stone on 24.10.16
Seminar renal stone on 24.10.16Seminar renal stone on 24.10.16
Seminar renal stone on 24.10.16
azmery saima
 
Urinary lithiasis 6
Urinary lithiasis 6Urinary lithiasis 6
Urinary lithiasis 6
Ahmed Eliwa
 
Renal calculi
Renal calculiRenal calculi
Renal calculi
zarishfazil
 
Cholelithiaisis
CholelithiaisisCholelithiaisis
Cholelithiaisis
santusan
 
2nd year_SGD_Physiology of Liver & Gallbladder.ppt
2nd year_SGD_Physiology of Liver & Gallbladder.ppt2nd year_SGD_Physiology of Liver & Gallbladder.ppt
2nd year_SGD_Physiology of Liver & Gallbladder.ppt
munshi5
 
CHOLELITHIASIS
CHOLELITHIASISCHOLELITHIASIS
CHOLELITHIASIS
Muthu Rajathi
 
Alternatives to Cholecystectomy for Cholelithiasis
Alternatives to Cholecystectomy for CholelithiasisAlternatives to Cholecystectomy for Cholelithiasis
Alternatives to Cholecystectomy for Cholelithiasis
Abdulkareem Kabir
 
Theories of calculus formation.pptx
Theories of calculus formation.pptxTheories of calculus formation.pptx
Theories of calculus formation.pptx
AmritaDas46
 
renal stone.ppt
renal stone.pptrenal stone.ppt
renal stone.ppt
OmarKhaleel6
 
renal stone.ppt
renal stone.pptrenal stone.ppt
renal stone.ppt
OmarKhaleel6
 
Renal calculi
Renal calculiRenal calculi
Renal calculi
Cerin Mathew Mathew
 
Stone disease evaluation in Pathology laboratory: Current prospective.
Stone disease evaluation in Pathology laboratory: Current prospective.Stone disease evaluation in Pathology laboratory: Current prospective.
Stone disease evaluation in Pathology laboratory: Current prospective.
Sanjeev Mehta
 
Urinary stone disease
Urinary stone diseaseUrinary stone disease
Urinary stone disease
Christos Argyropoulos
 
RENAL CALCULI PRESENTATION FINAL COPY.pptx
RENAL CALCULI  PRESENTATION FINAL COPY.pptxRENAL CALCULI  PRESENTATION FINAL COPY.pptx
RENAL CALCULI PRESENTATION FINAL COPY.pptx
HowardSakala
 
Laxatives 131016093818-phpapp02
Laxatives 131016093818-phpapp02Laxatives 131016093818-phpapp02
Laxatives 131016093818-phpapp02
SBCST
 
Kidneystonesmichelbeyan4
Kidneystonesmichelbeyan4Kidneystonesmichelbeyan4
Kidneystonesmichelbeyan4
romswinckel
 
Dental Caries_913b23e481f06c2ea9b2bb670af40b0d.pdf
Dental Caries_913b23e481f06c2ea9b2bb670af40b0d.pdfDental Caries_913b23e481f06c2ea9b2bb670af40b0d.pdf
Dental Caries_913b23e481f06c2ea9b2bb670af40b0d.pdf
FyslZargary
 
Urolithiasis ( Kidney Stones) For ClinicalMedicine.pptx
Urolithiasis ( Kidney Stones) For ClinicalMedicine.pptxUrolithiasis ( Kidney Stones) For ClinicalMedicine.pptx
Urolithiasis ( Kidney Stones) For ClinicalMedicine.pptx
BarikielMassamu
 
Laxatives
LaxativesLaxatives
Laxatives
Chinni Krishna
 

Similar to urolithiasis by dr newaz (20)

Dental calculus and predisposing factors
Dental calculus and predisposing factorsDental calculus and predisposing factors
Dental calculus and predisposing factors
 
Seminar renal stone on 24.10.16
Seminar renal stone on 24.10.16Seminar renal stone on 24.10.16
Seminar renal stone on 24.10.16
 
Urinary lithiasis 6
Urinary lithiasis 6Urinary lithiasis 6
Urinary lithiasis 6
 
Renal calculi
Renal calculiRenal calculi
Renal calculi
 
Cholelithiaisis
CholelithiaisisCholelithiaisis
Cholelithiaisis
 
2nd year_SGD_Physiology of Liver & Gallbladder.ppt
2nd year_SGD_Physiology of Liver & Gallbladder.ppt2nd year_SGD_Physiology of Liver & Gallbladder.ppt
2nd year_SGD_Physiology of Liver & Gallbladder.ppt
 
CHOLELITHIASIS
CHOLELITHIASISCHOLELITHIASIS
CHOLELITHIASIS
 
Alternatives to Cholecystectomy for Cholelithiasis
Alternatives to Cholecystectomy for CholelithiasisAlternatives to Cholecystectomy for Cholelithiasis
Alternatives to Cholecystectomy for Cholelithiasis
 
Theories of calculus formation.pptx
Theories of calculus formation.pptxTheories of calculus formation.pptx
Theories of calculus formation.pptx
 
renal stone.ppt
renal stone.pptrenal stone.ppt
renal stone.ppt
 
renal stone.ppt
renal stone.pptrenal stone.ppt
renal stone.ppt
 
Renal calculi
Renal calculiRenal calculi
Renal calculi
 
Stone disease evaluation in Pathology laboratory: Current prospective.
Stone disease evaluation in Pathology laboratory: Current prospective.Stone disease evaluation in Pathology laboratory: Current prospective.
Stone disease evaluation in Pathology laboratory: Current prospective.
 
Urinary stone disease
Urinary stone diseaseUrinary stone disease
Urinary stone disease
 
RENAL CALCULI PRESENTATION FINAL COPY.pptx
RENAL CALCULI  PRESENTATION FINAL COPY.pptxRENAL CALCULI  PRESENTATION FINAL COPY.pptx
RENAL CALCULI PRESENTATION FINAL COPY.pptx
 
Laxatives 131016093818-phpapp02
Laxatives 131016093818-phpapp02Laxatives 131016093818-phpapp02
Laxatives 131016093818-phpapp02
 
Kidneystonesmichelbeyan4
Kidneystonesmichelbeyan4Kidneystonesmichelbeyan4
Kidneystonesmichelbeyan4
 
Dental Caries_913b23e481f06c2ea9b2bb670af40b0d.pdf
Dental Caries_913b23e481f06c2ea9b2bb670af40b0d.pdfDental Caries_913b23e481f06c2ea9b2bb670af40b0d.pdf
Dental Caries_913b23e481f06c2ea9b2bb670af40b0d.pdf
 
Urolithiasis ( Kidney Stones) For ClinicalMedicine.pptx
Urolithiasis ( Kidney Stones) For ClinicalMedicine.pptxUrolithiasis ( Kidney Stones) For ClinicalMedicine.pptx
Urolithiasis ( Kidney Stones) For ClinicalMedicine.pptx
 
Laxatives
LaxativesLaxatives
Laxatives
 

Recently uploaded

Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
History of Stoke Newington
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
simonomuemu
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
eBook.com.bd (প্রয়োজনীয় বাংলা বই)
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
WaniBasim
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
Priyankaranawat4
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
adhitya5119
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
Celine George
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 

Recently uploaded (20)

Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
The History of Stoke Newington Street Names
The History of Stoke Newington Street NamesThe History of Stoke Newington Street Names
The History of Stoke Newington Street Names
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Smart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICTSmart-Money for SMC traders good time and ICT
Smart-Money for SMC traders good time and ICT
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.Types of Herbal Cosmetics its standardization.
Types of Herbal Cosmetics its standardization.
 
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdfবাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
বাংলাদেশ অর্থনৈতিক সমীক্ষা (Economic Review) ২০২৪ UJS App.pdf
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
 
Main Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docxMain Java[All of the Base Concepts}.docx
Main Java[All of the Base Concepts}.docx
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 

urolithiasis by dr newaz

  • 2. Objectives • to be able to enumerate the different causes of urinary stones • to be able to discuss the pathogenesis of stone formation • to be able to explain the different Physicochemical phases of stone formation • to be enumerate the different inhibitors of crystal formation • To be able to discuss the classification of renal stones
  • 3. References: • Campbell-Walsh Urology 10th ed • https://scialert.net/fulltext/?doi=ajdd.2017.54.62#424020_ja • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410535/ • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250668/
  • 4. epidemiology of renal calculi • Global annual prevalence rate: 3% - 5% • Life time prevalence: 15%-25% • rate of recurrence after 1st time: • 1st year: 14% • 5th year: 35% • 10th year: 52%
  • 5. epidemiology of renal calculi • Gender • Race/Ethnicity • Age • Geography • Climate • Occupation • BMI & Weight • Water • typically affects adult males than adult women • however, according to a study “..resource utilization for urinary stone disease rose 22% for men and 52% for women, reflecting an increasing resource use in women compared to men.” --
  • 6. epidemiology of renal calculi • Gender • Race/Ethnicity • Age • Geography • Climate • Occupation • BMI & Weight • Water • prevalence by Race is highest among white males> Hispanics> Asians> African-Americans
  • 7. epidemiology of renal calculi • Gender • Race/Ethnicity • Age • Geography • Climate • Occupation • BMI & Weight • Water • uncommon < 20 years old • peak incidence: 4th to 6th decade of life • in women, bimodal distribution of stone disease occurs • a 2nd peak occurs on the 6th decade corresponding to the onset of menopause
  • 8. epidemiology of renal calculi • Gender • Race/Ethnicity • Age • Geography • Climate • Occupation • BMI & Weight • Water • roughly follows environmental risk factors • higher prevalence in: • hot • arid • dry climates
  • 9. epidemiology of renal calculi • Gender • Race/Ethnicity • Age • Geography • Climate • Occupation • BMI & Weight • Water • seasonal variation in stone disease is likely related to temperature by way of fluid losses from perspiration & sunlight induced increases in vitamin D
  • 10. epidemiology of renal calculi • Gender • Race/Ethnicity • Age • Geography • Climate • Occupation • BMI & Weight • Water • occupational risk factors: • heat exposure • dehydration • occupations associated with increase risk: • cooks • engineering personnel • steel workers
  • 11. epidemiology of renal calculi • Gender • Race/Ethnicity • Age • Geography • Climate • Occupation • BMI & Weight • Water • prevalence & incident risk are directly correlated with weight and BMI in both sexes • higher BMI associated w/ increase excretion of: • Urinary oxalate • Uric Acid • Sodium • Phosphorus
  • 12. epidemiology of renal calculi • Gender • Race/Ethnicity • Age • Geography • Climate • Occupation • BMI & Weight • Water • urinary supersaturation of uric acid increases with increasing BMI • association of obesity w/ calcium oxalate stone formation is primarily due to increased excretion of promoters of stone formation • association of obesity and uric acid stone is primarily influenced by urinary pH
  • 13. epidemiology of renal calculi • Gender • Race/Ethnicity • Age • Geography • Climate • Occupation • BMI & Weight • Water • water intake is inversely related to kidney stone formation • geographical differences on incidence of stone disease have been associated to the difference in the mineral & electrolyte content of water
  • 14. physicochemistry • stone formation is a cascade of events that occurs as the glomerular filtrate traverses the nephron • starts w/ urine becoming supersaturated w/ respect to stone forming salts • crystals that are formed may flow with the urine • however, some crystals become retained in the kidney thru anchoring sites that promote growth and aggregation of crystal leading to stone formation
  • 15. physicochemistry state of saturation • concentration product: a solution containing ions/ molecules of a sparingly soluble salt • Saturated solution: a state when a pure aqueous solution of a salt reaches the point at which no further added salt crystals will dissolve • addition of crystals to a saturated solution will cause crystals to precipitate • precipitation is influenced by: • urine pH • temperature
  • 16. physicochemistry state of saturation • in urine however, crystallization does not necessarily occur because of the presence of inhibitors and other molecules that may allow higher concentration of salts without precipitation • urine is considered to be metastable with respect to the salt • Formation product: the point where the metastable state of urine can no longer be held in solution so that crystal would already form
  • 17. physicochemistry state of saturation • Three major states of saturation in urine: • undersaturated • metastable • unstable • crystals would not form • dissolution of crystals theoretically can be done
  • 18. physicochemistry state of saturation • Three major states of saturation in urine: • undersaturated • metastable • unstable • state were most common stone components reside • precipitation does not occur • modulation of factors controlling stone formation may be done • therapeutic intervention is performed at this state
  • 19. physicochemistry state of saturation • Three major states of saturation in urine: • undersaturated • metastable • unstable • nucleation will occur • inhibitors not generally effective
  • 20. physicochemistry metastable urine state • crystal growth can occur on existing crystal, but de novo formation of crystals cannot occur in the length of time it normally takes for the filtered urine to reach the bladder • BUT crystal formation may occur on certain conditions
  • 21. physicochemistry metastable urine state: circumstances when crystals may grow 1. parts of the nephron where local concentration products may exceed the formation product for long enough time periods to allow nucleation to occur 2. local areas of obstruction/ stasis in the upper urinary tract may prolong urinary transit time and allow crystals to form 3. microscopic impurities/ other constituents in the urine can facilitate the nucleation process by absorption of the crystal components in a geometric way that ensemble the native crystals
  • 22. physicochemistry Nucleation & Crystal growth, aggregation and retention • Homogenous nucleation is the process by which nuclei form in pure solution • Nuclei are the earliest crystal structure that does not dissolve • Small nuclei is unstable favoring dissolution of the crystal over crystal growth • Nuclei would persist if: • supersaturation level is reached • size of the crystal is adequate • urine transit time is longer that the lag time to nucleation
  • 23. physicochemistry Nucleation & Crystal growth, aggregation and retention • crystal growth occurs when: • promoters stabilize the nuclei thus providing a surface with a binding site that accommodates the crystal structure of the nucleus • crystal nuclei usually form through heterogeneous nucleation by adsorption onto existing surfaces of epithelial cells, cell debris or other crystals • Inhibitors of crystal growth • Magnesium • Citrate • Nephrocalcin • Tamm-Horsfall mucoprotein • Uropontin • Bikunin
  • 24. physicochemistry two views on formation & growth of crystals • Free-particle mechanism, tubular plugs • Fixed-particle mechanism, papillary plaques • starts with formation of crystals inside the nephron • if the crystals are removed it becomes harmless crystalluria • if not, retention of crystals leads either to: • particles too large to pass • particles adhere to damaged cells
  • 25. physicochemistry two views on formation & growth of crystals • Free-particle mechanism, tubular plugs • Fixed-particle mechanism, papillary plaques • retained crystals can: • enter the interstitium • form plugs inside tubules/ ducts of Bellini • crystal plugs were seen in patients w/: • primary hyperoxaluria • primary hyperparathyroidism • enteric hyperoxaluria • distal renal tubular acidosis
  • 26. physicochemistry two views on formation & growth of crystals • Free-particle mechanism, tubular plugs • Fixed-particle mechanism, papillary plaques • these conditions have increase serum and renal load of Calcium, Oxalate & Cystine: • primary hyperoxaluria • primary hyperparathyroidism • enteric hyperoxaluria • high renal load leads to increased intratubular concentrations further increasing crystallization
  • 27. physicochemistry two views on formation & growth of crystals • Free-particle mechanism, tubular plugs • Fixed-particle mechanism, papillary plaques • overall, plugs consist of random aggregates formed due to an acute high supersaturation of stone components
  • 28. physicochemistry two views on formation & growth of crystals • Free-particle mechanism, tubular plugs • Fixed-particle mechanism, papillary plaques • initial step in papillary plaque formation is precipitation of calcium phosphate in the interstitium around the bends of the longest loops of Henle • with alternating accumulation of crystal components and organic material these deposits increase in size • the growing plaque gets exposed to the urine space outside the papilla
  • 29. physicochemistry two views on formation & growth of crystals • Free-particle mechanism, tubular plugs • Fixed-particle mechanism, papillary plaques • Plaque formation in the interstitium may form during periods of increased reabsorption of calcium & phosphate • this leads to a supersaturation in the interstitial space • since water in the interstitium is static this allows the salts to crystalize
  • 30. physicochemistry two views on formation & growth of crystals • Free-particle mechanism, tubular plugs • Fixed-particle mechanism, papillary plaques • overall, this mechanism contains an initial period of deposition outside the dynamics of urine flow • this is followed by growth and eventual exposure to urine
  • 31. physicochemistry inhibitors & promoters of crystal formation • presence of molecules that raises the supersaturation needed to initiate crystal nucleation/ reduce rate of crystal growth to prevent stone formation have been identified • Known Inhibitors of crystal formation: • Citrate • Magnesium • Pyrophosphate
  • 32. physicochemistry inhibitors & promoters of crystal formation • Known Inhibitors of crystal formation: • Citrate • Magnesium • Pyrophosphate • acts as an inhibitor of calcium oxalate and calcium phosphate stone formation by: • complexes with calcium to decrease available ionic calcium for binding with oxalate or phosphate • inhibits spontaneous precipitation of calcium oxalate
  • 33. physicochemistry inhibitors & promoters of crystal formation • Known Inhibitors of crystal formation: • Citrate • Magnesium • Pyrophosphate • acts as an inhibitor of calcium oxalate and calcium phosphate stone formation by: cont.. • prevents agglomeration of calcium oxalate • reduced calcium phosphate growth • prevents heterogeneous nucleation of calcium oxalate by monosodium urate
  • 34. physicochemistry inhibitors & promoters of crystal formation • Known Inhibitors of crystal formation: • Citrate • Magnesium • Pyrophosphate • it’s action is derived from its complex with oxalate • this complex reduces available ionic oxalate concentrations and decrease calcium oxalate supersaturation • it also reduces the rate of calcium oxalate crystal growth
  • 35. physicochemistry inhibitors & promoters of crystal formation • Known Inhibitors of crystal formation: • Citrate • Magnesium • Pyrophosphate • inorganic pyrophosphate is responsible for 25% - 50% of the inhibitory activity of whole urine against calcium phosphate crystallization
  • 36. physicochemistry inhibitors & promoters of crystal formation • Known Inhibitors of calcium oxalate monohydrate crystal aggregation: • Nephrocalcin glycoprotein • Tamm-Horsfall glycoprotein • Osteopontin/ Uropontin • is an acidic glycoprotein that is synthesized in the proximal convoluted tubules and the thick ascending limb • inhibits growth of calcium oxalate monohydrate crystals
  • 37. physicochemistry inhibitors & promoters of crystal formation • Known Inhibitors of calcium oxalate monohydrate crystal aggregation: • Nephrocalcin glycoprotein • Tamm-Horsfall glycoprotein • Osteopontin/ Uropontin • expressed by renal epithelial cells in the thick ascending limb and distal convoluted tubule as a membrane- anchored protein that is released into the urine after the anchoring site is cleaved by phospholipase or proteases • most abundant protein in the urine • potent inhibitor of calcium oxalate crystal aggregation
  • 38. physicochemistry inhibitors & promoters of crystal formation • Known Inhibitors of calcium oxalate monohydrate crystal aggregation: • Nephrocalcin • Tamm-Horsfall glycoprotein • Osteopontin/ Uropontin • expressed in bone matrix and renal epithelial cells of the ascending limb of the loop of Henle and distal tubule • inhibits nucleation, growth and aggregation of calcium oxalate crystal • also reduces binding of crystals to renal epithelial cells
  • 39. mineral metabolism • Calcium absorption primarily occurs in the small intestines at a rate that is dependent on calcium intake • 1,25-Dihydroxyvitamin D, is the most potent stimulator of intestinal calcium absorption • PTH stimulate 1α-hydroxylase in the proximal tubule of the kidney to convert 25-dihydroxyvitamin D3 to 1,25(OH)2D3 • PTH enhances proximal tubular reabsorption of calcium and renal phosphate excretion • Intestinal oxalate absorption is influenced by luminal calcium, magnesium and oxalate-degrading bacteria
  • 40. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones
  • 41. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • nearly 75% of all urinary calculi contain calcium • Hypercalciuria • most common abnormality identified • but not all persons w/ hypercalciuria develop stones
  • 42. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Hypercalciuria • stone formation may occur with: • increase urinary saturation of calcium salts • decrease inhibitory activity of citrate & chondroitin sulfate
  • 43. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Hypercalciuria • definitions: • > 200 mg urinary calcium/day, after adherence to a 400 mg calcium, 100 mg sodium diet x 1 week (Menon, 1986) • excretion of greater than 4 mg/kg/day or greater than 7 mmol/day in men and 6 mmol/day in women (Parks and Coe, 1986)
  • 44. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Hyperoxaluria • definitions: urinary oxalate >40 mg/day • leads to urinary saturation of calcium oxalate that leads to calcium oxalate stones formation • it is also involve in crystal growth and retention by means of renal tubular cell injury by lipid peroxidation and generation of oxygen free radicals
  • 45. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Hyperoxaluria may be due to: • primary hyperoxaluria • derangement in biosynthesis • enteric hyperoxaluria (malabsorption conditions) • inflammatory bowel disease • celiac sprue • intestinal resection • Dietary hyperoxaluria • excessive dietary intake of vitamin C
  • 46. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Hyperuricosuria • urinary uric acid > 600mg/day • 10% of calcium stone formers have hyperuricosuria as the only abnormality • most common cause is increase dietary intake of purine
  • 47. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Hypocitraturia • urinary citrate level of: • < 320 mg/day (Park, 1987) • < 0.6 mmol (men), 1.03 mmol (women)/day (Menon and Mahle, 1983) • cause by: • metabolic acidosis due to enhanced renal tubular reabsorption • decrease synthesis of citrate in peritubular cells
  • 48. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Low Urine pH • defined as: < 5.5 • may be due to: • high amount of dissociated uric acid • chronic metabolic acidosis • gouty diathesis- formation of urinary stones in persons w/ 1o gout
  • 49. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Renal Tubular Acidosis • characterized by metabolic acidosis resulting from defects in renal tubular hydrogen ion secretion/ bicarbonate reabsorption • Types of RTA: • Type 1 • Type II • Type III
  • 50. Renal Tubular Acidosis • Normal: kidney must reabsorb filtered bicarbonate to maintain buffering action • Excess acid must likewise be excreted • failure of the two mechanism lead to metabolic acidosis: • decrease buffer (bicarbonate) • increase acid (decrease acid secretion in the tubules) • RTA occurs due to an impairment of • net acid excretion (Type1) • reabsorption of bicarbonate (Type 2)
  • 51. types of renal tubular acidosis • Type 1 (Distal) • Type 2 (Proximal) • Type 4 (Distal) • characterized by an abnormal collecting duct function w/c is the inability to acidify the urine in the presence of systemic acidosis • classic findings: • hypokalemia • hypercholerimia • non-anion gap metabolic acidosis • nephrocalcinosis • elevated urine (>6.0)
  • 52. types of renal tubular acidosis • Type 1 (Distal) • Type 2 (Proximal) • Type 4 (Distal) • most common associated stone is Calcium Phosphate because of: • hypercalciuria • hypocitraturia: most important factor in stone formation for type 1 • increased urinary pH • Metabolic acidosis promote: • bone demineralization • which lead to hyperparathyroidism • Hypercalceuria
  • 53. types of renal tubular acidosis • Type 1 (Distal) • Type 2 (Proximal) • Type 4 (Distal) • characterized by a defect in bicarbonate reabsorption associated with: • initial high urine pH that normalizes as plasma HCO3 - decreases • decrease in amount of filtered HCO3 - • nephrolithiasis is uncommon due to a normal citrate excretion • affects the proximal tubule function • Stone is not common due to a normal citrate excretion
  • 54. types of renal tubular acidosis • Type 1 (Distal) • Type 2 (Proximal) • Type 4 (Distal) • associated w/ chronic renal damage seen in patients w/ • interstitial renal disease • diabetic nephropathy • stone formation is not common due to a reduced excretion of stone-forming substances such as calcium and uric acid
  • 55. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Hypomagnesuria • rare cause of nephrolithiasis • magnesium binds with oxalate and calcium thus reducing Mg inhibitory activity • Low urinary Mg level associated with decreased urinary citrate levels, w/c. further contributes to stone formation
  • 56. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • determinants of uric acid stone formation • low pH • most important pathogenic factor • low urine volume • hyperuricosuria • stone formation may be due to: • congenital causes • acquired causes • idiopathic causes
  • 57. uric acid stone formation causes • Congenital disorders • Acquired • Idiopathic • associated with: • Defects in renal tubular urate reabsorption • Lesch-Nyhan syndrome • 1o a defect in purine metabolism • deficiency of hypoxanthine-guanine phosphoribosyltransferase (HGPRT) • leads to build up of uric acid in all body fluids
  • 58. uric acid stone formation causes • Congenital disorders • Acquired • Idiopathic • associated with: • Familial Juvenile Gouty Nephropathy • characterized by elevated serum uric acid concentrations • due to abnormal reabsorption of uric acid
  • 59. uric acid stone formation causes • Congenital disorders • Acquired • Idiopathic • chronic diarrhea • volume depletion • myeloproliferative disorders • high animal protein intake • intake of uricosuric drugs (ex. colchicine, allopurinol)
  • 60. uric acid stone formation causes • Congenital disorders • Acquired • Idiopathic • gouty diathesis/ idiopathic low urine pH • manifest with: • normal uric acid levels (does not have gout) • acidic urine • Hyperuricosuric calcium nephrolithiasis • manifest with: • hyperuricosuria • normal urine pH
  • 61. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • main component is cystine • due to crystallization of cystine in urine • Factors determining crystallization of cystine in urine: • urinary cystine concentration • urine pH • ionic strength • urinary macromolecules
  • 62. Factors determining crystallization of cystine in urine • urinary cystine concentration • urine pH • ionic strength • urinary macromolecules • supersaturation of cystine in the urine is the main contributor • due to: • no specific inhibitor for cystine crystallization • poor solubility of cystine in urine
  • 63. Factors determining crystallization of cystine in urine • urinary cystine concentration • urine pH • ionic strength • urinary macromolecules • cystine solubility is pH dependent • Solubility of cystine at particular pH: • 300 mg/L : pH 5 • 400 mg/L: pH 7 • 1000 mg/L: pH 9 • Average urine pH: 6
  • 64. Factors determining crystallization of cystine in urine • urinary cystine concentration • urine pH • ionic strength • urinary macromolecules • Ionic strength influences the solubility of cystine • so that an increase in ionic strength of urine from 0.005 to 0.3 will allow an addition of 70 mg of cystine to be dissolved
  • 65. Factors determining crystallization of cystine in urine • urinary cystine concentration • urine pH • ionic strength • urinary macromolecules • colloids can also increase cystine solubility • but the mechanism is still unclear
  • 66. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • primarily composed of Magnesium Ammonium Phosphate Hexahydrate called struvite • prerequisite in its formation is infection with a urease-producing bacteria • urinary urea is hydrolyzed to ammonia + CO2 (produces alkaline urine, pH 7.2 - 8.0)
  • 67. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • but alkaline pH favors the formation of ammonia • however in the presence of urease, ammonia continues to be produced despite the alkaline pH • this further increases the pH of urine
  • 68. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Alkaline pH also promotes hydration of CO2 to Carbonic acid • Carbonic acid dissociates into bicarbonate + 2 Hydrogen ions
  • 69. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Dihydrogen phosphate in the alkaline urine promotes dissociation to produce phosphate ions • Add Magnesium into the mixture you would have: • Ammonium + Phosphate + Magnesium = Magnesium Ammonium Phosphate • Infection stones may also be exacerbated with: • urinary obstruction • urine stasis
  • 70. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Calcium Stones • Uric Acid Stones • Cystine Stones • Infection Stones • Miscellaneous Stones • Common pathogens associated: • Proteus • P. mirabilis: most common organism causing struvite stones • Klebsiella • Pseudomonas • Staphylococcus • incidence is higher in women than in men (2:1)
  • 71. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Miscellaneous Stones • Xanthine & Dihydroxyadenine Stones • Ammonium Acid Urate Stones • Matrix Stones • Medication-Related Stones • radiolucent stone formed due to: • congenital deficiency of xanthine oxidase • results into plasma accumulation and excess urinary excretion of xanthine • xanthine is poorly soluble in urine leading to supersaturation with the subsequent development of xanthine stones
  • 72. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Miscellaneous Stones • Xanthine & Dihydroxyadenine Stones • Ammonium Acid Urate Stones • Matrix Stones • Medication-Related Stones • radiolucent stone formed due to: • congenital deficiency of adenine phosphoribosyltransferase (APRT) • leads to formation and hyperexcretion of dihydroxyadenine (DHA) • low solubility of DHA leads to precipitation and formation of urinary crystals that may grow and form urinary stones
  • 73. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Miscellaneous Stones • Xanthine & Dihydroxyadenine Stones • Ammonium Acid Urate Stones • Matrix Stones • Medication-Related Stones • rare cause of urinary stones, seen in <1% of all stone formers • conditions associated include: • laxative abuse • recurrent UTI • recurrent uric acid stone formation • inflammatory bowel disease
  • 74. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Miscellaneous Stones • Xanthine & Dihydroxyadenine Stones • Ammonium Acid Urate Stones • Matrix Stones • Medication-Related Stones • Pathophysiology has been postulated to be due to: • dehydration 2o GI losses (from abuse of laxatives) causing: • intracellullar acidosis • enhanced ammonia excretion • Urinary sodium is low because of dehydration • urate complexes with ammonia leading to urinary supersaturation of ammonium acid urate
  • 75. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Miscellaneous Stones • Xanthine & Dihydroxyadenine Stones • Ammonium Acid Urate Stones • Matrix Stones • Medication-Related Stones • also known as fibromas/ colloid calculi/ albumin calculi • such stones are made of mucopolysaccharide (1/3) + protein (2/3)
  • 76. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Miscellaneous Stones • Xanthine & Dihydroxyadenine Stones • Ammonium Acid Urate Stones • Matrix Stones • Medication-Related Stones • most common amino acids found were: • threonine • leucine • serine • tyrosine • arginine • lysine
  • 77. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Miscellaneous Stones • Xanthine & Dihydroxyadenine Stones • Ammonium Acid Urate Stones • Matrix Stones • Medication-Related Stones • formation may be due to: • direct precipitation and crystallization of a drug or its metabolite • indirectly by altering the urinary environment favorable for metabolic stone formation
  • 78. pathogenesis of upper urinary tract calculi classification of nephrolithiasis • Miscellaneous Stones • Xanthine & Dihydroxyadenine Stones • Ammonium Acid Urate Stones • Matrix Stones • Medication-Related Stones • Drugs associated with calcium stone formation • loop diuretics (furosemide) • acetazolamide: a carbonic anhydrase inhibitor • topiramate: use for seizure disorders and migraine • zonisamide: sulfonamide anticonvulsant and carbonic anhydrase inhibitor
  • 79. anatomic predisposition to stone formation • Ureteropelvic Junction Obstruction • Horseshoe kidneys • Caliceal Diverticula • Medullary sponge kidney
  • 80. anatomic predisposition to stone formation • Ureteropelvic Junction Obstruction • Horseshoe kidneys • Caliceal Diverticula • Medullary sponge kidney • incidence of renal stones in this abnormality is about 20% • however studies show that metabolic abnormalities play a big role in the development of urinary stones among these patients
  • 81. anatomic predisposition to stone formation • Ureteropelvic Junction Obstruction • Horseshoe kidneys • Caliceal Diverticula • Medullary sponge kidney • evidence on the role of metabolic predisposition: • high rate of recurrence of stone formation after correction • metabolic evaluation demonstrated an underlying metabolic abnormality • type and distribution of metabolic abnormality identified in UJO patients where similar to the general population
  • 82. anatomic predisposition to stone formation • Ureteropelvic Junction Obstruction • Horseshoe kidneys • Caliceal Diverticula • Medullary sponge kidney • therefore: correction of UPJ obstruction does not prevent stone formation from recurring
  • 83. anatomic predisposition to stone formation • Ureteropelvic Junction Obstruction • Horseshoe kidneys • Caliceal Diverticula • Medullary sponge kidney • occurs in 0.25% of the population and renal stone incidence among them is 20% • because of the high insertion of the ureter into the renal pelvis there is impairment of urine drainage
  • 84. anatomic predisposition to stone formation • Ureteropelvic Junction Obstruction • Horseshoe kidneys • Caliceal Diverticula • Medullary sponge kidney • Although, risk of stone formation has been related to urinary stasis • underlying metabolic abnormalities are still needed for the formation of stones
  • 85. anatomic predisposition to stone formation • Ureteropelvic Junction Obstruction • Horseshoe kidneys • Caliceal Diverticula • Medullary sponge kidney • associated in 40% of patients w/ stones • unclear if the stone formation is caused by local obstruction or because of metabolic factors
  • 86. anatomic predisposition to stone formation • Ureteropelvic Junction Obstruction • Horseshoe kidneys • Caliceal Diverticula • Medullary sponge kidney • characterized by ectasia of the renal collecting ducts • associated with: • recurrent infection • urinary stasis • hypercalciuria • impaired renal concentrating ability • defective urinary acidification
  • 87. anatomic predisposition to stone formation • Ureteropelvic Junction Obstruction • Horseshoe kidneys • Caliceal Diverticula • Medullary sponge kidney • possible contributing factor for stone formation: • defective renal acidification • Hypercalciuria • Hypocitraturia
  • 88. stones in pregnancy • physiologic changes during pregnancy may enhance stone formation • physiologic hydronephrosis brought about by: • high levels of progesterone • compression of the ureters by the gravid uterus • Hydronephrosis may persist up to 4 to 6 weeks postpartum • physiologic dilatation may: • promote crystallization due to urinary stasis • increase renal pelvic pressure
  • 89. stones in pregnancy • Other physiologic changes that may modulate risk factors for the development of urinary stone • increase renal blood flow • increase GFR • increase filtered loads of: • calcium • sodium • uric acid
  • 90. thank you • supplementary online material: • https://scialert.net/fulltext/?doi=ajdd.2017.54.62#424020_ja • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410535/ • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5250668/